WO2009027762A3 - Formes posologiques liquides d'antibiotiques fluoroquinolone ou sel de ceux-ci pour administration ophtalmique, otique et nasale - Google Patents

Formes posologiques liquides d'antibiotiques fluoroquinolone ou sel de ceux-ci pour administration ophtalmique, otique et nasale Download PDF

Info

Publication number
WO2009027762A3
WO2009027762A3 PCT/IB2007/002878 IB2007002878W WO2009027762A3 WO 2009027762 A3 WO2009027762 A3 WO 2009027762A3 IB 2007002878 W IB2007002878 W IB 2007002878W WO 2009027762 A3 WO2009027762 A3 WO 2009027762A3
Authority
WO
WIPO (PCT)
Prior art keywords
otic
ophthalmic
nasal administration
salt
dosage forms
Prior art date
Application number
PCT/IB2007/002878
Other languages
English (en)
Other versions
WO2009027762A2 (fr
Inventor
Chandrashekhar Mainde
Girish Shantilal Achliya
Suresh Parasmal Bora
Rajendra Nandlal Nagori
Original Assignee
Wockhardt Research Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Research Centre filed Critical Wockhardt Research Centre
Publication of WO2009027762A2 publication Critical patent/WO2009027762A2/fr
Publication of WO2009027762A3 publication Critical patent/WO2009027762A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention porte sur des solutions stables pour administration ophtalmique, otique ou nasale. Les solutions contiennent un antibiotique fluoroquinolone ou des sels de celui-ci et un acide aminé, facultativement en combinaison avec un ou plusieurs médicaments pour le traitement d'infections bactériennes. L'invention porte en outre sur des solutions stables pour administration ophtalmique, otique ou nasale qui contiennent de la nadifloxacine et des sels pharmaceutiquement acceptables de celle-ci. L'invention porte également sur des procédés de préparation desdites solutions stables.
PCT/IB2007/002878 2007-08-24 2007-10-02 Formes posologiques liquides d'antibiotiques fluoroquinolone ou sel de ceux-ci pour administration ophtalmique, otique et nasale WO2009027762A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1624/MUM/2007 2007-08-24
IN1623/MUM/2007 2007-08-24
IN1623MU2007 2007-08-24
IN1624MU2007 2007-08-24

Publications (2)

Publication Number Publication Date
WO2009027762A2 WO2009027762A2 (fr) 2009-03-05
WO2009027762A3 true WO2009027762A3 (fr) 2012-11-29

Family

ID=40387932

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002878 WO2009027762A2 (fr) 2007-08-24 2007-10-02 Formes posologiques liquides d'antibiotiques fluoroquinolone ou sel de ceux-ci pour administration ophtalmique, otique et nasale

Country Status (1)

Country Link
WO (1) WO2009027762A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2502616A1 (fr) * 2011-03-21 2012-09-26 Matthew Krayenbuhl Composition pharmaceutique nasale
CN104546696A (zh) * 2013-10-28 2015-04-29 南京长澳医药科技有限公司 一种s-(-)-那氟沙星-l-精氨酸单剂量滴眼液及其制备工艺
CA3022675A1 (fr) * 2017-04-14 2018-10-18 Wockhardt Limited Compositions antibacteriennes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040176337A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
US20040176321A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drugs
US20050065164A1 (en) * 2001-04-25 2005-03-24 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US7164023B2 (en) * 2003-09-04 2007-01-16 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
US7247642B2 (en) * 1999-05-07 2007-07-24 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247642B2 (en) * 1999-05-07 2007-07-24 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
US20050065164A1 (en) * 2001-04-25 2005-03-24 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US20040176337A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
US20040176321A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drugs
US7164023B2 (en) * 2003-09-04 2007-01-16 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate

Also Published As

Publication number Publication date
WO2009027762A2 (fr) 2009-03-05

Similar Documents

Publication Publication Date Title
MX2009005603A (es) Compuestos de urea policiclicos antibacterianos.
WO2006087543A8 (fr) Composés antibactériens dérivés de pipéridine
WO2008020227A3 (fr) Composés chimiques
WO2008020229A3 (fr) Composés chimiques
WO2010038081A3 (fr) Dérivés hétérocycliques et procédés d’utilisation associés
WO2007071965A3 (fr) Composes chimiques
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
WO2006092599A3 (fr) Composes chimiques
MX2014011537A (es) Formulaciones parenterales para la administracion de antibioticos macrolidos.
WO2007117661A3 (fr) Microparticules médicamenteuses
WO2011107436A3 (fr) Solutions transparentes aqueuses de fluocinolone acétonide dans le traitement de l'inflammation otique
WO2006087544A8 (fr) Composes chimiques
UA91205C2 (ru) Антибиотическая комбинация амикацина и цефепима для создания общего раствора для лечения инфекций
WO2006087548A3 (fr) Composes chimiques
MY148124A (en) Preparation of a crystalline antibiotic substance
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
WO2005081821A3 (fr) Formes polymorphes de derives de ketolides bicycliques 6-11
WO2007133796A3 (fr) Procédés et compositions de traitement de l'apnée du sommeil
WO2009027762A3 (fr) Formes posologiques liquides d'antibiotiques fluoroquinolone ou sel de ceux-ci pour administration ophtalmique, otique et nasale
WO2006065301A3 (fr) Compositions pour le traitement d'infections de l'oreille
WO2017158616A8 (fr) Composés de carbapénème
WO2009061445A3 (fr) Utilisation de composés immunomodulateurs pour le traitement de troubles associés à un dysfonctionnement endothélial
WO2018065917A3 (fr) Composition de tensioactif pulmonaire synthétique pour le traitement d'affections pulmonaires

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825232

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07825232

Country of ref document: EP

Kind code of ref document: A2